LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Streck Launches Rapid, Modular qPCR Instrument with Market-Leading Speed

By LabMedica International staff writers
Posted on 11 Nov 2020
Image: Zulu RT (Photo courtesy of Streck)
Image: Zulu RT (Photo courtesy of Streck)
Streck (La Vista, NE, USA) has launched the Zulu RT, a rapid, modular qPCR instrument capable of performing four independent experiments simultaneously. It can perform a 40-cycle, 6-channel 3-step real-time PCR in less than 20 minutes, making it the fastest qPCR instrument in the world.

The Zulu RT uses unique, proprietary Streck thermal technology combined with powerful optics for market-leading speed. The Zulu RT does not sacrifice test volume for speed; it provides less than 20-minute qPCR for volumes from 10 up to 50 µL. Ramp speeds of 15°C/second heating, 12°C/second cooling and precise thermal control allows the Zulu RT to perform rapid, 6-color detection faster than any other instrument in the world for large volumes.

The modularity of the system allows greater flexibility in testing, allowing multiple users at one time; in essence, acting as four individual thermal cyclers in one. The Zulu RT can speed assay development and ease sample processing backlogs and scheduling for busy laboratories. Designed for speed and flexibility, the Zulu RT is ideally suited for esoteric testing, rapid needs testing and research use.


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Silver Member
PCR Plates
Diamond Shell PCR Plates

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more